This compound is a pharmaceutical intermediate characterized by a triazine ring structure with an amino group and a thioxo group. Its primary significance lies in its use as a building block for the synthesis of other chemical entities.
Alcance del contenido: La información de esta página se refiere a la identificación química y a los contextos de suministro industrial, investigación y producción. No constituye una afirmación terapéutica, un consejo médico ni instrucciones de uso de medicamentos.
¿Adquiriendo o suministrando este compuesto?
Publique su inventario o una solicitud de compra
CAS 33509-43-2
2-(2-Nitrovinyl)thiophene
Pharmaceutical intermediate compound
4,4'-(6-Chloropyrimidine-2,4-diyl)dimorpholine
Pharmaceutical intermediate compound
N-(3-(2-(2-chloropyrimidin-4-yl)acetyl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide
Pharmaceutical intermediate compound
4-(5-BROMO-3-CHLOROPYRIDIN-2-YL)MORPHOLINE
Pharmaceutical intermediate compound
1-Bromo-2-butyne
pharmaceutical intermediate
4-Methoxy-N-methyl-2-nitrobenzenamine
Pharmaceutical intermediate
(R)-methyl4-((3R,5S,8R,9S,10S,13R,14S,17R)-3-(tert-butyldimethylsilyloxy)-10,13-dimethyl-7-oxo-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoate-R28549
steroid intermediate for API synthesis
Methyl 6-bromo-2-naphthoate
pharmaceutical intermediate
4-amino-6-tert-butyl-3-sulfanylidene-2H-1,2,4-triazin-5-one
OFKAVNQBCRJBJE-UHFFFAOYSA-N
CC(C)(C)C1=NNC(=S)N(C1=O)N
—